Steroid‐Induced Psychosis in a Child With Nephrotic Syndrome Secondary to Focal Segmental Glomerulosclerosis: A Case Report Authors: Sushan Pokharel, Amrit Bhusal, Himal Bikram Bhattarai, Tek Nath Yogi, Prabha Bhandari, Deepti Pandit Published: 2024 ABSTRACT ABSTRACTCorticosteroid‐induced psychosis is rare and less reported in children compared to adults. However, psychosis is considered a severe adverse effect of corticosteroids in pediatric nephrotic syndrome. Steroid‐induced psychosis is dose‐dependent and should be treated by tapering the dose of steroids and usually initiating an atypical antipsychotic. A 13‐year‐old male child presented to the pediatrics outpatient department with complaints of anxiety, fearfulness, and seeing images of an old man crawling into his room and threatening to strangle him with a red rope, which led to decreased sleep. He was initiated on oral prednisolone 3 weeks ago after being diagnosed with nephrotic syndrome. A diagnosis of steroid‐induced psychosis was made, and he was tapered on steroids over 6 weeks. He was then initiated on tacrolimus, quetiapine, and lorazepam and was discharged after a week. At follow‐up in 4 weeks, his psychosis had resolved, and nephrotic syndrome was found to improve. Children on steroids should be closely monitored for psychotic symptoms over a prolonged duration. Although tapering the dose of steroids is the gold standard treatment of steroid‐induced psychosis, cases like nephrotic syndrome demand the continuous use of an immunosuppressant. In such cases, tacrolimus has been found to be an effective alternative, although continuous monitoring for nephrotoxicity is necessary. Similarly, atypical antipsychotics (like quetiapine) are preferred for psychosis because of their lesser risk for extrapyramidal side effects compared to typicals. Parental counseling and informed consent are utmost for children on steroids or tacrolimus. Summary Psychosis is a rare and less reported side‐effect of steroids in children compared to adults.However, it is severe in children with nephrotic syndrome and should be monitored over a prolonged period.Tacrolimus is an effective alternative immunosuppressant. Parental counseling is the utmost for children on steroids or tacrolimus. Summary Psychosis is a rare and less reported side‐effect of steroids in children compared to adults.However, it is severe in children with nephrotic syndrome and should be monitored over a prolonged period.Tacrolimus is an effective alternative immunosuppressant. Parental counseling is the utmost for children on steroids or tacrolimus. Psychosis is a rare and less reported side‐effect of steroids in children compared to adults. Psychosis is a rare and less reported side‐effect of steroids in children compared to adults. However, it is severe in children with nephrotic syndrome and should be monitored over a prolonged period. However, it is severe in children with nephrotic syndrome and should be monitored over a prolonged period. Tacrolimus is an effective alternative immunosuppressant. Parental counseling is the utmost for children on steroids or tacrolimus. Tacrolimus is an effective alternative immunosuppressant. Parental counseling is the utmost for children on steroids or tacrolimus. Abbreviation Diagnostic and Statistical Manual of Mental Disorders, 5th edition Introduction Corticosteroids have historically been used to treat a wide range of illnesses, such as inflammatory and immunologic disorders, chronic obstructive pulmonary disease, asthma, vasculitis, systemic lupus erythematosus (SLE), and back pain [1]. On the other hand, they have a range of adverse effects that affect immunological, metabolic, gastrointestinal, dermatological, endocrine, ophthalmological, and other organ systems, including psychiatric disorders. The incidence of psychiatric disorders due to steroid therapy is estimated to be around 6% [2]; however, many more people suffer from mild symptoms, insufficient to fulfill a diagnosis [3]. Psychiatric side effects commonly include mood disorders, delirium, anxiety and panic disorder, behavioral abnormalities, isolated cognitive deficits (in memory, attention, and concentration), and less frequently, psychosis [1, 4]. In addition to being rare, cases of steroid‐induced psychosis are less likely to be reported because most of them resolve without intervention, and not all of them are severe or long‐lived [5], thus contributing to the paucity of available research on the subject. Furthermore, compared to adults, psychosis due to corticosteroid therapy is rare and less reported in children and adolescents [3, 6] Corticosteroids are also an important therapeutic agent for children and adolescents with nephrotic syndrome, including those secondary to focal segmental glomerulosclerosis (FSGS). In patients with nephrotic syndrome, psychosis in particular is considered a severe side effect of corticosteroid therapy [6]. To our knowledge, less than ten case‐reports of steroid‐induced psychosis in childhood nephrotic syndrome exist in the literature. The dose of corticosteroids is a significant predictor of risk of steroid‐induced psychosis, and besides that, no other strong predictors have been established [1], although females are found to be more prevalent than males [1, 6]. Despite the lack of any Food and Drug Administration (FDA)‐approved medications [5], the management of steroid‐induced psychosis is primarily done by reducing the dose or by discontinuing the steroid and initiating an antipsychotic [7] or even intravenous immunoglobulin [8]. Consequently, the time taken for steroid‐induced psychosis to resolve depends on the early discontinuation of steroids and initiation of pharmacotherapy [9]. The preferred pharmacotherapy for psychosis is atypical antipsychotics. Atypical antipsychotics such as risperidone can also be used as a prophylactic agent in cases with a high risk of psychosis [6]. Besides, calcineurin inhibitors are considered efficacious alternatives to steroids for the treatment of nephrotic syndrome. A commonly used calcineurin inhibitor is tacrolimus, which is particularly used for steroid‐resistant nephrotic syndrome, although it works in both steroid‐dependent and steroid‐resistant forms [10]. It has also been widely established as the steroid‐sparing therapy of choice for steroid‐dependent nephrotic syndrome; however, rituximab has sometimes been considered a safer option owing to its nephroprotective nature [11]. We hereby present a rare case of a male child undergoing treatment for nephrotic syndrome who developed psychosis due to steroids. Case History/Examination A 13‐year‐old male child was brought to the pediatric outpatient department with the chief complaints of disturbed behavior, increased anxiety, fearfulness, and visual sensation of a man creeping on the walls. He stayed with his parents and elder brother. Upon further questioning his elder brother, it was found that while sleeping, he used to see an old man (imaginary) creeping on the wall and threatening to kill him by a method of strangulation using a red‐colored rope. Because of this, his night time sleep duration reduced from 8 h initially to 2 h. During the daytime, the patient used to avoid going to his room because of the fear that the same person (old man) would harm him. Throughout the day, the patient seemed worried and afraid, and there was no daytime somnolence. The patient had been diagnosed with nephrotic syndrome 3 weeks back. During that time, he was brought to our hospital by his parents with the chief complaint of gradually increasing generalized body swelling and periorbital edema over a period of 2 weeks. The swelling initially started from the peri‐orbital region and then progressed bilaterally to the legs and finally to the abdomen. He also had a history of frothy urine along with generalized body swelling. There was no history of burning micturition, cola‐colored urine, sore throat, rashes or jaundice. There was no family history of a similar illness. On examination, the vitals were within normal limits. There was bilateral pitting edema over both legs extending to the knee joint, periorbital edema, and abdominal distension. The rest of the systemic examination results were normal. Methods Laboratory investigations at the earlier presentation had revealed a clinical picture of nephrotic syndrome. Serum albumin level was found to be 1.4 g/dL. Renal biopsy revealed findings suggestive of focal segmental glomerulosclerosis (Figure 1). Oral prednisolone at 2 mg/kg/day (a total of 80 mg daily in two equally divided doses) was initiated, and the patient was scheduled for a follow‐up in a period of 2 weeks. However, the patient did not follow‐up in 2 weeks and landed in our pediatric clinic 3 weeks after the initiation of prednisolone, still on the dose of steroid prescribed (80 mg/day) and with the symptoms mentioned above. A section from kidney showing a glomeruli with segmental sclerosis, with rest of the surrounding tubules appearing unremarkable (400× PAS stain). He was admitted and psychiatric consultation was performed, which revealed the presence of negative symptoms. All other organic pathologies were excluded by investigations, such as electroencephalogram (EEG) and computed tomography (CT) scan. Based on the diagnostic and statistical manual of mental disorders, 5th edition (DSM‐5) criteria, he was diagnosed with steroid‐induced psychosis. Serum albumin at this time was 2.2 g/dL and proteinuria was 3+ on dipstick. Steroid therapy was tapered over a period of 6 weeks followed by initiation on immunosuppressant therapy (tacrolimus at 4 mg/day in two divided doses of 2 mg orally). He was also given an antipsychotic (quetiapine) to resolve the psychiatric symptoms, and a benzodiazepine (lorazepam) to help him sleep at night. He was discharged after a week of discontinuation of the steroid and was arranged for a follow‐up in a period of 2 weeks. Serum albumin level at discharge was 3.7 g/dL and there were no features of nephrotoxicity (Figure 2). Timeline showing progression of psychosis, changes in proteinuria and steroid levels, and medications provided. Discussion Steroids are widely used medications for multiple disorders. However, steroid‐induced psychosis is more common in diseases causing low serum albumin levels (e.g., nephrotic syndrome) than other diseases treated with steroids (e.g., chronic obstructive pulmonary disease) [6]. Steroids are inactive when bound to albumin, thus active (free) form of steroids is higher in patients with hypoalbuminemia [12]. Hypoalbuminemia, thus exposes the patients to more side effects [12, 13]. Similarly, people on drugs that increase plasma corticosteroid levels, particularly those with damaged blood–brain barrier, are among the other ones at risk of steroid‐induced psychosis [5]. In contrast, our case did not have any drug increasing steroid levels, nor did it have a damaged blood–brain barrier. Common psychiatric side effects of steroids are headache, mood disorders, depression, and insomnia [8]. Steroid‐induced psychosis, according to the DSM‐5 criteria, includes the development of delusions or hallucinations after steroid use, with no other existing explanation of symptoms [14]. The DSM‐5 is the fifth edition of the reference book called “Diagnostic and Statistical Manual of Mental Disorders,” that consists of classifications and criteria (the DSM‐5 criteria) used to diagnose mental health and brain related disorders. In our case, insomnia and psychosis were seen as side effects of steroids early on after the therapy, while the presence of visual hallucinations helped us reach the diagnosis. Females on high high‐dose steroids (> 40 mg/day) for a long duration and with a history of psychiatric illness have usually been considered to be at major risk for steroid‐induced psychosis [6], although some studies deny the risk with a history of psychiatric illness [1]. This was partially contrary to our case, in which a male patient with no psychiatric history was administered with a short‐term steroid. The patient, however, was on a high dose steroid. In children, high‐dose corticosteroids increase predisposition to anxiety and aggression [8]. This was consistent with the case in the discussion, in which the patient was very anxious; however, he was not aggressive. Regarding the characteristics of psychosis, our patient developed visual hallucinations, marked by an old man threatening to kill him by strangulation with a red‐colored rope, which led to increased anxiety. This is in unison with the case by Harshitha et al., who developed visual hallucinations with persecutory delusions, anxiety and insomnia [3]. In contrast, the case by Bartra et al. developed auditory hallucinations [5]. The case by Kim et al. and Hegruner et al. developed both auditory and visual hallucinations, along with persecutory delusions and insomnia [6, 8]. Besides hallucinations, persecutory delusions, anxiety and insomnia, the common characteristics associated with psychosis among other published case‐reports include talking to self, aggressive behavior, and mood changes. These characters in a child with steroids for nephrotic syndrome should prompt immediate assessment and psychiatric consultation. Steroid‐induced psychosis, unlike in the case discussed above, usually occurs 2 weeks after the administration of steroids [6]. Because of the quick onset, children treated with steroids should be evaluated for psychiatric effects within a week of steroid treatment [6]. Our case was presented 3 weeks after the initiation of steroids. This signifies the necessity of follow‐up for a substantially prolonged period of time in patients on steroids. Parents should be warned about the potential of changes in mood/affect, behavioral, and cognitive function in their children at the time of steroid initiation [6]. Another important need for prolonged follow‐up is to monitor the relapse, in which case our patient was planned on tacrolimus 4 mg/day, along with a low dose steroid because of its potential for psychosis at higher doses. Although tacrolimus takes a long time for the onset of action [10], it is the immunosuppressant of choice for patients with steroid‐resistant nephrotic syndrome [15]. It is also considered the steroid‐sparing therapy of choice for steroid‐dependent nephrotic syndrome and steroid‐induced psychosis. A study reported that 15 out of 16 children with steroid‐resistant nephrotic syndrome underwent complete recovery after 120 days of tacrolimus therapy [16]. Another study revealed that 95% of patients underwent complete or partial remission after 6 months of co‐therapy with tacrolimus and a low‐dose corticosteroid [17]. In our case, the steroid was tapered immediately at the patient's presentation with psychosis and tacrolimus was initiated after discontinuation of the steroid. The patient's clinical signs and symptoms improved with tacrolimus on follow‐up at 4 weeks (5 weeks of tacrolimus use). Similarly, laboratory investigations revealed improvement in nephrotic syndrome with tacrolimus, although complete remission was yet to be achieved. The limitations of our study lie in the potential nephrotoxicity associated with tacrolimus use. This prompts the necessity of repeated monitoring for nephrotoxicity, and may even require renal biopsies especially in smaller children [15]. Moreover, this demands a prolonged follow‐up period. A 1‐year follow up was found to be associated with lower nephrotoxic effects and higher remission rates, according to a study demonstrating co‐therapy with tacrolimus and a low‐dose steroid [17]. However, some cases of tacrolimus use do not achieve remission. The potential for chronic kidney disease in the absence of remission must be discussed with parents before starting tacrolimus [16]. Most patients with steroid‐induced psychosis show improvement by tapering the dose of steroids alone. However, a few patients do not improve completely and require pharmacotherapy or electroconvulsive therapy [5]. Antipsychotics are commonly used as pharmacotherapy for psychosis. Atypical antipsychotics are preferred over typical antipsychotics because of the higher risk of extrapyramidal side effects that necessitate the use of anticholinergics [8]. Moreover, the risk of extrapyramidal side effects was found to be higher in the pediatric age group compared to the adults [6]. Taking this into account, we initiated treatment with quetiapine (an atypical antipsychotic) after tapering him with steroids, which led to rapid improvement in his psychosis. Psychosis due to steroids usually takes approximately 1 week to resolve after discontinuation of steroids, while mood‐related symptoms may persist for up to 6 weeks [18]. Consequently, in a total of 6 weeks, approximately 90% of cases of steroid‐induced psychosis are resolved [2]. In contrast, our case was found to have an indolent course, as it improved significantly only at 3 weeks and resolved only at 5 weeks of discontinuation of steroid. Conclusion and Results In his follow‐up at 2 weeks, the psychiatric symptoms and sleep cycle were found to improve. Another follow‐up was scheduled at 4 weeks, when his psychiatric symptoms were found to resolve and the sleep cycle was maintained. Repeat investigations in line with nephrotic syndrome were improving. Despite being the therapy of choice for children with nephrotic syndrome, steroids can produce a variety of side effects, involving different organ systems. Steroid‐induced psychosis is a rare but severe side effect of steroids in children with nephrotic syndrome. Our case report focuses on the notion that close observation and follow‐up are needed in a child diagnosed with nephrotic syndrome who is started with steroids. In addition, immunosuppressants such as tacrolimus can also be used as an alternative therapy for nephrotic syndrome in patients with features of steroid‐induced psychosis; however, serial monitoring and prolonged follow‐up are necessary to rule out nephrotoxicity. Author Contributions Sushan Pokharel: formal analysis, investigation, methodology, project administration, software, validation, visualization, writing – original draft, writing – review and editing. Amrit Bhusal: conceptualization, data curation, investigation, project administration, resources, software, writing – original draft. Himal Bikram Bhattarai: conceptualization, data curation, methodology, resources, supervision, validation, writing – review and editing. Tek Nath Yogi: formal analysis, investigation, project administration, validation, writing – review and editing. Prabha Bhandari: conceptualization, data curation, resources, validation, writing – review and editing. Deepti Pandit: conceptualization, data curation, resources, validation, writing – review and editing. Ethics Statement The authors have nothing to report. Consent Verbal and written informed consent was taken from the patient's guardian for publication of this case report and the accompanying images. A copy of the written consent is available for review by the Editor‐in‐Chief of this journal on request. Conflicts of Interest The authors declare no conflicts of interest. Permission to Reproduce Permitted with appropriate citation (except for commercial purposes).